on MTS US
Innovative Breakthroughs in Aesthetic Medicine: Dr. Maria Fedchuk’s Contributions
The 22nd Aesthetic & Anti-Aging Medicine World Congress in Monaco showcased a major innovation in beauty and health. Dr. Maria Fedchuk introduced the "EXOSOMAL LIQUID LASER," an advanced treatment protocol she developed through extensive clinical trials.
At the same event, Dermoaroma's RADIANCE from the PEELING SYSTEM received the "Aesthetic Medicine Award." Dr. Fedchuk's scientific expertise supported this achievement. With FDA approval, these technologies are now available in the U.S. through MTS US.
Dr. Fedchuk, a fourth-generation physician from Ukraine, co-founded MTS US. She has led advancements in aesthetic medicine, including the use of non-human exosomes and secretomes.
Her 18 years in the field, combined with her role as a scientific advisor and trainer, position her as a global leader in aesthetic medicine. Her work emphasizes patient safety and innovation, particularly in regenerative and anti-aging treatments.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MTS US news